Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы

J. B. Ravzatov

Работ: 7

Andijan State Medical Institute

  1. Parameters of blood short-chain peptides and digestive hydrolases in patients with chronic hepatitis B virus infection

    M. A. Zhuraeva, Владимир Алексеевич Алейник, N. D. Ashuralieva +3

    СтатьяNeuropeptides and Animal PhysiologyRussian Journal of Infection and Immunity2021Цитирований: 0
    ABI

  2. PREVALENCE AND CAUSES OF LIVER CIRRHOSIS IN DIFFERENT REGIONS LITERATURE REVIEW

    J. B. Ravzatov, Dildora Abdumalikovna Nabieva

    СтатьяLiver Disease Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  3. PREVALENCE AND CAUSES OF LIVER CIRRHOSIS IN DIFFERENT REGIONS LITERATURE REVIEW

    J. B. Ravzatov, Dildora Abdumalikovna Nabieva

    СтатьяLiver Disease Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  4. PROGNOSTIC SIGNIFICANCE OF IMMUNOGENETIC MARKERS IN THE EARLY ASSESSMENT OF DECOMPENSATION RISK IN LIVER CIRRHOSIS

    Boburjon Rasulov, J. B. Ravzatov

    СтатьяLiver Disease and TransplantationZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  5. HORMONAL AND GENETIC MECHANISMS OF METABOLIC-ASSOCIATED STEATOTIC LIVER DISEASE IN WOMEN OF REPRODUCTIVE AGE

    Dilfuza Yunusova, J. B. Ravzatov

    СтатьяLiver Disease Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  6. HORMONAL AND GENETIC MECHANISMS OF METABOLIC-ASSOCIATED STEATOTIC LIVER DISEASE IN WOMEN OF REPRODUCTIVE AGE

    Dilfuza Yunusova, J. B. Ravzatov

    СтатьяLiver Disease Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI

  7. PROGNOSTIC SIGNIFICANCE OF IMMUNOGENETIC MARKERS IN THE EARLY ASSESSMENT OF DECOMPENSATION RISK IN LIVER CIRRHOSIS

    Boburjon Rasulov, J. B. Ravzatov

    СтатьяLiver Disease and TransplantationZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0
    ABI